600 patients66,869 observations120 daysLIVE

Patient P-01330

Synthetic patientNBL-101 · Day 106 · 75+ · F · baseline S14Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Stable
GI state
Improving
Inflammatory state
Stable
Nutritional resilience
Improving
Discontinuation risk
64%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S14
  2. Day 44 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 50 GI-04 recommendedGI Support Protocol GI-04
  4. Day 51 Patient acceptedStarted GI-04 in the companion
  5. Day 57 ME-01 recommendedMonitoring Escalation ME-01
  6. Day 58 Patient acceptedStarted ME-01 in the companion
  7. Day 59 GI symptom burden −28% vs expectedGI Support Protocol GI-04
  8. Day 61 Deterioration detected before clinical escalationMonitoring Escalation ME-01
  9. Day 65 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 44.

Primary contributors, last 14 days
  • Nutritional resilience+9
  • GI instability-4

What helped?

  • GI Support Protocol GI-04Day 50
    Result: symptom burden −28%
  • Monitoring Escalation ME-01Day 57
    Result: deterioration detected before clinical escalation
LIFE OS recommendation
Dietary Support Protocol NP-02
56%
probability of meaningful tolerance improvement
  • 284 similar trajectories
  • 66% showed improvement
  • median effect visible after 10 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden
Companion
47.7/100
stable · +1.7 vs previous 14 d
Toxicity
Blood
42.4/100
improving · -10.3 vs previous 14 d
Sleep quality
Wearable
37.1/100
improving · +2.5 vs previous 14 d
Energy level
Daily log
3.2/10
improving · +0.4 vs previous 14 d
Stress level
Daily log
6.5/10
stable · -0.0 vs previous 14 d
Steps
Wearable
5,023
stable · +108 vs previous 14 d
Adherence
Companion
46.6 %
stable · -0.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards restoration · 34 from the failing basin, 53 from restoration.

Would help
  • NP-02 Dietary Support Protocol
    63% improved among 64 similar · onset 10 d · confidence 67%
  • SC-12 Supportive Compound
    76% improved among 51 similar · onset 6 d · confidence 67%
  • CR-01 Clinician Review
    100% improved among 8 similar · onset 5 d · confidence 67%
Would not help
  • Keep fat low
    GI +4.9 next day on high-intake days · n 26
  • Keep histamine low
    GI +3.9 next day on high-intake days · n 20
  • Keep simple carbs low
    GI +3.1 next day on high-intake days · n 24
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Dietary fat load
    +4.9detractor · 95%
  • Histamine load
    +3.9detractor · 95%
  • Simple carbohydrates
    +3.1detractor · 84%
  • Spicy / capsaicin
    +2.6detractor · 73%
  • Alcohol
    -0.7no signal · 17%
  • Insoluble fibre
    +0.4no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 80
    • DNAFUT2 non-secretor lowers mucosal fucosylation
    • MicrobiomeAkkermansia low → thinner mucus layer
    • Daily logGI symptom score 48 and rising
  • Inflammatory signalling 65
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • BloodInflammatory load index 52
    • WearableHRV 26 ms, trending down
  • Butyrate / short-chain fatty acid production 55
    • MicrobiomeButyrate capacity 24/100
    • Daily logFibre intake low in recent food logs
  • Autonomic recovery 25
    • WearableResting HR 75 bpm
  • Drug metabolism and exposure 20
    • BloodToxicity index 42
DNA
Fictional pharmacogenomic panel
  • FUT2 rs601338 AA (non-secretor)
    Reduced mucosal fucosylation
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 2 · butyrate capacity 24/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiNormal
  • Bacteroides fragilisNormal
  • Bifidobacterium longumLow
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
23 ms
Sleep
6.6 h
Steps
3,568
Resting HR
77 bpm
Daily log: GI score 48, nutritional resilience 50, adherence 47.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
  • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Track each bowel movement today: time, stool form, urgency, overnight waking
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • Electrolyte solution, one sachet after any loose stool
  • Fictional demo item: oral nutrition supplement with lunch

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0180422%S19AD-05improved61
P-0169630%S20CR-01improved59
P-0170830%S07CR-01improved59
P-0137129%S06CR-01improved63
P-0144229%S13CR-01improved61
P-0183529%S17CR-01improved56
P-0138827%S17CR-01improved59
P-0187727%S01CR-01improved67
P-0143023%S05CR-01improved54
P-0176722%S14DT-01no change63
P-0170963%S14GI-04improved43
P-0166156%S03GI-04improved52